E-LIB Suche - Ergebnisse für: Hauke, Ralph J

1

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab..:

Weiss, Sarah A. ; Sznol, Mario ; Shaheen, Montaser...
Clinical Cancer Research. 30 (2023) 1 - p. 74-81 , 2023

Link: https://doi.org/10.1158/..

2

Incorporating radioligand therapy in clinical practice in t..:

Calais, Jeremie ; Eulau, Stephen M. ; Gardner, Linda...
Cancer Treatment Reviews. 115 (2023) - p. 102524 , 2023

Link: https://doi.org/10.1016/..

3

A Phase 1/2, open label dose-escalation and expansion trial..:

Jonasch, Eric ; Hauke, Ralph ; Falchook, Gerald...
The Oncologist. 28 (2023) Supplement_1 - p. S12-S12 , 2023

Link: https://doi.org/10.1093/..

4

A Phase I Study of Capivasertib in Combination With Abirate..:

Shore, Neal ; Mellado, Begoña ; Shah, Satish...
Clinical Genitourinary Cancer. 21 (2023) 2 - p. 278-285 , 2023

Link: https://doi.org/10.1016/..

5

Concurrent durvalumab and radiation therapy (DUART) followe..:

Joshi, Monika ; Tuanquin, Leonard ; Zhu, Junjia...
Journal for ImmunoTherapy of Cancer. 11 (2023) 2 - p. e006551 , 2023

Link: https://doi.org/10.1136/..

6

Phase II Clinical and Translational Study of Everolimus ± P..:

Jun, Tomi ; Hahn, Noah M ; Sonpavde, Guru...
The Oncologist. 27 (2022) 6 - p. 432-e452 , 2022

Link: https://doi.org/10.1093/..

7

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzu..:

Aggarwal, Charu ; Prawira, Amy ; Antonia, Scott...
Journal for ImmunoTherapy of Cancer. 10 (2022) 4 - p. e004424 , 2022

Link: https://doi.org/10.1136/..

8

An Open–Label, Randomized, Multi–Center Study Comparing the..:

Hasanov, Merve ; Milton, Denái R. ; Sharfman, William H....
OncoImmunology. 10 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

9

Long-Term Progression-Free Survival of Patients with Metast..:

Clark, Joseph I ; Curti, Brendan ; Davis, Elizabeth J...
Journal of Investigative Medicine. 69 (2021) 4 - p. 888-892 , 2021

Link: https://doi.org/10.1136/..

10

Safety and Efficacy of Nivolumab in Patients With Advanced ..:

McFarlane, Joshua J. ; Kochenderfer, Mark D. ; Olsen, Mark R....
Clinical Genitourinary Cancer. 18 (2020) 6 - p. 469-476.e4 , 2020

Link: https://doi.org/10.1016/..

11

Safety and Efficacy of Nivolumab in Patients With Advanced ..:

Vogelzang, Nicholas J. ; Olsen, Mark R. ; McFarlane, Joshua J....
Clinical Genitourinary Cancer. 18 (2020) 6 - p. 461-468.e3 , 2020

Link: https://doi.org/10.1016/..

12

A phase 2, randomized trial evaluating the combination of d..:

Voss, Martin H. ; Bhatt, Rupal S. ; Vogelzang, Nicholas J....
Cancer. 125 (2019) 14 - p. 2400-2408 , 2019

Link: https://doi.org/10.1002/..

13

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in..:

Galsky, Matthew D. ; Wang, Huan ; Hahn, Noah M....
European Urology. 73 (2018) 5 - p. 751-759 , 2018

Link: https://doi.org/10.1016/..

14

Pembrolizumab and platinum-based chemotherapy as first-line..:

Gadgeel, Shirish M. ; Stevenson, James P. ; Langer, Corey J....
Lung Cancer. 125 (2018) - p. 273-281 , 2018

Link: https://doi.org/10.1016/..

15

Impact of Sequencing Targeted Therapies With High-dose Inte..:

Clark, Joseph I. ; Wong, Michael K.K. ; Kaufman, Howard L....
Clinical Genitourinary Cancer. 15 (2017) 1 - p. 31-41.e4 , 2017

Link: https://doi.org/10.1016/..